Melatonin attenuates disruption of serum cholesterol status in rats with a single α-naphthylisothiocyanate treatment

Journal of Pineal Research

Volumn 42, Issue 2, 2007, Pages 159-165

  Ohta, Yoshiji ^a   Kongo Nishimura, Mutsumi ^a   Imai, Yoichiro ^b   Kitagawa, Akira ^c  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c Chukyo Women's University   (Japan)

Author keywords

naphthylisothiocyanate; Liver cholesterol; Melatonin; Serum and liver total bile acid; Serum cholesterol status

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; BILE ACID; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELATONIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

1-NAPHTHYLISOTHIOCYANATE; ANIMALS; CHOLESTASIS; CHOLESTEROL; MALE; MELATONIN; RATS; RATS, WISTAR;

EID: 33846927059     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00397.x     Document Type: Article

References (39)

1. CAPIZZO F, ROBERTS RJ. α-Naphthylisothiocyanate (ANIT)-induced hepatotoxicity and disposition in various species. Toxicol Appl Pharmacol 1971; 19:176-187.
2. RODRÍGUEZ-GARAY EA. Cholestasis: human disease and experimental animal models. Ann Hepatol 2003; 2:150-158.
3. ROTH RA, DAHM LJ. Neutrophil- and glutathione-mediated hepatotoxicity of α-naphthylisothiocyanate. Drug Met Rev 1997; 29:153-165.
4. DAHM LJ, SCHULTZE AE, ROTH RA. An antibody of neutrophils attenuates α-naphthylisothiocyanate-induced liver injury. J Pharmacol Exp Ther 1991; 256:412-420.
5. HILL DA, ROTH RA. α-Naphthylisothiocyanate causes neutrophils to release factors that are cyotoxic to hepatocytes. Toxicol Appl Pharmacol 1998; 148:169-175.
6. HILL DA, JEAN PA, ROTH RA. Bile duct epithelial cells exposed to alpha-naphthylisothiocyanate produces a factor that causes neutrophil-dependent hepatocellular injury in vitro. Toxicol Sci 1999; 47:118-125.
7. KONGO M, OHTA Y, NISHIDA K et al. An association between lipid peroxidation and α-naphthylisothiocyanate- induced liver injury in rats. Toxicol Lett 1999; 105:103-110.
8. OHTA Y, KONGO M, SASAKI E et al. Change in hepatic antioxidant defense system with liver injury development in rats with a single α-naphthylisothiocyanate intoxication. Toxicology 1999; 139:265-275.
9. KATTERMANN VR, WOLFRUM DI. Cholesterol metabolism and plasma lecithin-cholesterol acyl transferase in experimental hepatitis and cholestasis in the rat. Z Klin Chem Klin Biochem 1970; 8:413-419.
10. MITAMURA T. Alterations of high density lipoproteins in experimental intrahepatic cholestasis in the rat induced by administration of α-naphthylisothiocyanate. J Biochem 1984; 95:29-36.
11. CHISHOLM JW, DOLPHIN PJ. Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasis. J Lipid Res 1996; 37:1086-1098.
12. OHTA Y, KONGO M, NISHIDA K et al. Preventive effects of Saiko-keishi-to and Shigyaku-san extracts on changes in levels of serum and liver lipid components with the progression of hepatobiliary injury in rats injected with α-naphthylisothiocyanate. J Trad Med 1998; 15:57-63.
13. CHILHOLM JW, PATERNITI JR, DOLPHIN PJ. Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-1 transgenic rats is diminished through dose-dependent apolipoprotein A-1 activation of LCAT. Biochim Biophys Acta 2000; 1487:145-154.
14. WATERS NJ, HOLMES E, WILLIAMS A et al. NMR and pattern recognition studies on the time-related metabolic effects of α-naphthylisothiocyanate on liver, urine, and plasma in the rat: an intergrative metabonomic approach. Chem Res Toxicol 2001; 14:1401-1412.
15. OHTA Y, KONGO-NISHIMURA M, IMAI Y et al. α-Tocopherol protects against α-naphthylisothiocyanate-induced hepatotoxicity in rats less effectively than melatonin. Chem-Biol Interactions 2006; 161:115-124.
16. CHISHOLM JW, NATION P, DOLPHIN PJ et al. High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesis. Am J Physiol 1990; 276:G1165-G1173.
17. TALLET F, VASSON MP, COUDERC R et al. Characterization of lipoproteins during human cholestasis. Clin Chim Acta 1996; 244:1-15.
18. SCHFFNER F, SCHARNBECK HH, HUTTERER F et al. Mechnism of cholestasis. VII. α-Naphthylisothicoyanate-induced jaundice. Lab Invest 1973; 28:321-331.
19. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
20. TAN DX, MANCHESTER LC, REITER RJ et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998; 253:614-620.
21. PIERI CP, MARRA M, MORINI F et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55:PL271-PL276.
22. ZANG LY, COSMA G, GARDNER H et al. Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998; 1425:469-477.
23. LONGONI B, SALGO MG, PRYOR WA et al. Effects of melatonin on lipid peroxidation by oxygen radicals. Life Sci 1998; 62:853-859.
24. ALLEGRA M, REITER RJ, TAN D-X et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
25. LOTUFO CMC, LOPES C, DUBOCOVICH ML et al. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol 2001; 430:351-357.
26. MORI N, AOYAMA H, MURASE T et al. Anti-hypercholesterolemic effect of melatonin in rats. Acta Pathol Jpn 1989; 39:613-618.
27. CHAN TY, TANG PL. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocr Res 1995; 21:681-696.
28. HOYOS M, GUERREO JM, PEREZ-CANO R et al. Serum cholesterol and lipid peroxidation decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000; 28:150-155.
29. AOYAMA H, MORI N, MORI W. Effect of melatonin on genetic hypercholesterolemia in rats. Atherosclerosis 1988; 69:269-272.
30. MONTILLA P, TÚNEZ I, MUÑOZ MC et al. Hyperlidemic nephropathy induced by adriamycin: effect of melatonin administration. Nephron 1997; 76:345-350.
31. MONTILLA P, TÚNEZ I, MUÑOZ MC et al. Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephrology induced by adriamycin in rats. J Pineal Res 1998; 25:86-93.
32. OHTA Y, KONGO M, SASAKI E et al. Protective effect of melatonin against α-naphthylisothiocyanate-induced liver injury in rats. J Pineal Res 2000; 29:15-23.
33. CALVO JR, REITER RJ, CARCÍA JJ et al. Characterization of the protective effects of melatonin and related indoles against α-naphthylisothiocyanate-induced liver injury in rats. J Cell Biochem 2001; 80:461-470.
34. OHTA Y, KONGO M, SASAKI E et al. Effect of melatonin on changes in hepatic antioxidant enzyme activities in rats treated with α-naphthylisothiocyanate. J Pineal Res 2001; 31:370-377.
35. ZLATKIS A, ZAK B. Study of a new cholesterol reagent. Anal Biochem 1969; 29:143-148.
36. LOWRY OH, ROSEBROUGH NH, FARR AD et al. Protein measurement with the Folin reagent. J Biol Chem 1951; 193:265-273.
37. ESQUIFINO A, AGRASAL C, VELÁZQUEZ E et al. Effect of melatonin on serum cholesterol and phospholipid levels, and on prolactin, thyroid-stimulating hormone and thyroid hormone levels, in hyperprolactinemic rats. Life Sci 1997; 61:1051-1058.
38. FABIŚ M, PRUSZYNSKA E, MACKOWAIK P. In vivo and in suit action of melatonin on insulin secretion and some metabolic implications in the rat. Pancreas 2002; 25:166-169.
39. KOSSOR D, MEUNIER PC, HANDLER JA et al. Temporal relationship of changes in hepatobiliary function and morphology in rats following a-naphthylisothiocyanate (ANIT) administration. Toxicol Appl Pharmacol 1993; 119:108-114.